Alan J. Russell

Chief Scientific Officer at Edgewise Therapeutics Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: Edgewise Therapeutics Inc., 3 years.

Edgewise Therapeutics Inc. Director ยท Chief Scientific Officer
3 years ยท Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 12, 2026 Edgewise Therapeutics Inc. Option exercise +5,781 โ€” โ€”
Aug 12, 2026 Edgewise Therapeutics Inc. Option exercise +7,031 โ€” โ€”
Aug 12, 2026 Edgewise Therapeutics Inc. Open-market sale โˆ’3,238 $43.68 $141,428
Aug 12, 2026 Edgewise Therapeutics Inc. Open-market sale โˆ’2,273 $43.68 $99,275
Aug 12, 2026 Edgewise Therapeutics Inc. Open-market sale โˆ’390 $44.46 $17,339
Jul 1, 2026 Edgewise Therapeutics Inc. Option exercise +130,352 $0.45 $58,658
Jul 1, 2026 Edgewise Therapeutics Inc. Option exercise +69,648 $0.18 $12,537
Jul 1, 2026 Edgewise Therapeutics Inc. Open-market sale โˆ’130,352 $39.41 $5,136,651
Jul 1, 2026 Edgewise Therapeutics Inc. Open-market sale โˆ’69,648 $39.41 $2,744,751
Nov 12, 2025 Edgewise Therapeutics Inc. Option exercise +100,000 $0.18 $18,000
Nov 12, 2025 Edgewise Therapeutics Inc. Open-market sale โˆ’100,000 $21.12 $2,112,000
Aug 26, 2025 Edgewise Therapeutics Inc. Option exercise +100,000 $0.18 $18,000
Aug 26, 2025 Edgewise Therapeutics Inc. Open-market sale โˆ’100,000 $14.60 $1,460,000
Aug 12, 2025 Edgewise Therapeutics Inc. Option exercise +5,781 โ€” โ€”
Aug 12, 2025 Edgewise Therapeutics Inc. Open-market sale โˆ’1,907 $13.39 $25,535

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.